Update on Gsap’s regulatory activity in pharma, biologics, cannabis, IVD and combination products

Here, we have assembled recent regulatory news items from pharma, biologics, cannabis and IVDs. Also, we present a few examples of recent projects from our Pharma/Biotech department.

COVID-19 and In vitro Diagnostics

In the days when the world is facing the corona epidemic, great efforts are being made to find medical solutions to diagnose the infection.Regulatory bodies have also joined the effort and issued guidelines that allow expedited approval of appropriate solutions.

This newsletter focuses on medical diagnostic solutions (IVD for COVID-19). The leaflet details the US, Europe and Israel approaches to accelerated approvals on the issue and also brings Gsap's experience and involvement in promoting related projects.
We wish good luck to the medical device industry, labs and startups in their wonderful initiatives.


Grant Proposal writing

It is already clear to all of our clients that 2020 will be a challenging year, with one of the main challenges being fundraising.

One of the services we provide is assistance with writing grant proposals. During the last month, in particular, due to the COVID-19 pandemic, we have helped clients prepare a large number of grant proposals. These proposals cover various segments of the biomed industry, including pharma (small molecules), biotechnology, cell therapy and medical devices (accessories, active devices, IVD and Digital Health).

Some of the grant proposal timelines are extremely tight.
We can support you in preparing and submitting your proposal, as well as prepare for and participate in meetings with the assessor.

Contact Us